Will BEAM-101 receive FDA approval for sickle cell therapy by end of 2025? | Binary | | | 14 days ago | |
Will Editas in-vivo sickle cell therapy enter clinical trials by October 2025? | Binary | | | 2 months ago | |
Will Vertex Pharmaceuticals win the lawsuit against HHS regarding Casgevy fertility support program by end of 2024? | Binary | | | 5 months ago | |
Which major pharma company will partner with Beam Therapeutics by end of 2025? | Categorical | | | 14 days ago | |
Will BEAM-101 outperform Reni-cel and Casgevy in clinical trials by end of 2025? | Binary | | | 14 days ago | |
Will Beam Therapeutics' stock increase by more than 20% by March 31, 2025? | Binary | | | 14 days ago | |
Will Editas secure a partner for ex-vivo sickle cell treatment by mid-2025? | Binary | | | 2 months ago | |
Will the court declare that Vertex's Casgevy fertility support program does not violate anti-kickback laws by end of 2024? | Binary | | | 5 months ago | |
Will Vertex Pharmaceuticals reach a settlement with HHS regarding Casgevy fertility support program by end of 2024? | Binary | | | 5 months ago | |
What will be the court ruling on whether Vertex's Casgevy fertility support program violates anti-kickback laws by end of 2024? | Categorical | | | 5 months ago | |
Will Vertex Pharmaceuticals reach a settlement with the US government over the Casgevy gene therapy fertility support program lawsuit by the end of 2024? | Binary | | | 5 months ago | |
Will the US government amend federal anti-kickback laws to allow fertility support programs for gene therapies like Casgevy by the end of 2024? | Binary | | | 5 months ago | |
Where will BEAM-101 be approved by end of 2025? | Categorical | | | 14 days ago | |
Which therapy will lead the market share for sickle cell treatment by end of 2025? | Categorical | | | 14 days ago | |
What will be the outcome of Editas in-vivo sickle cell therapy trials by end of 2025? | Categorical | | | 2 months ago | |
Will Editas achieve proof-of-concept for in-vivo sickle cell therapy by end of 2025? | Binary | | | 2 months ago | |
Which company will partner with Editas for ex-vivo sickle cell treatment by mid-2025? | Categorical | | | 2 months ago | |
Who will be the major competitor to Editas in-vivo sickle cell therapy by end of 2025? | Categorical | | | 2 months ago | |
What will be the resolution of Vertex Pharmaceuticals' lawsuit against HHS regarding Casgevy fertility support program by end of 2024? | Categorical | | | 5 months ago | |
What will be the outcome of Vertex Pharmaceuticals' lawsuit against HHS regarding Casgevy fertility support program by end of 2024? | Categorical | | | 5 months ago | |
What will be the public reaction to the court ruling in the Vertex Pharmaceuticals lawsuit over the Casgevy gene therapy fertility support program within 1 month of the ruling? | Categorical | | | 5 months ago | |
Will the court rule in favor of Vertex Pharmaceuticals in the Casgevy gene therapy fertility support program lawsuit by the end of 2024? | Binary | | | 5 months ago | |
What will be the outcome of the lawsuit between Vertex Pharmaceuticals and the US government over the Casgevy gene therapy fertility support program by the end of 2024? | Categorical | | | 5 months ago | |
How will Vertex Pharmaceuticals' stock price change within 1 week following the resolution of the Casgevy gene therapy fertility support program lawsuit? | Categorical | | | 5 months ago | |